PRQR logo

ProQR Therapeutics NV (PRQR) Total Liabilities

Annual Total Liabilities

$106.66 M
-$5.55 M-4.95%

31 December 2023

PRQR Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Quarterly Total Liabilities

$91.44 M
+$116.80 K+0.13%

01 September 2024

PRQR Quarterly Total Liabilities Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PRQR Total Liabilities Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-5.0%-9.7%
3 y3 years+105.6%+17.1%
5 y5 years+431.4%+286.1%

PRQR Total Liabilities High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3 years-5.0%+105.6%-18.5%+62.7%
5 y5 years-5.0%+431.4%-18.5%+483.6%
alltimeall time-5.0%>+9999.0%-18.5%+1341.7%

ProQR Therapeutics NV Total Liabilities History

DateAnnualQuarterly
Sept 2024
-
$91.44 M(+0.1%)
June 2024
-
$91.32 M(-5.0%)
Mar 2024
-
$96.17 M(-9.8%)
Dec 2023
$106.66 M(-4.9%)
$106.66 M(+5.3%)
Sept 2023
-
$101.29 M(-3.4%)
June 2023
-
$104.86 M(-3.2%)
Mar 2023
-
$108.29 M(-3.5%)
Dec 2022
$112.22 M(+2.9%)
$112.22 M(+99.6%)
Sept 2022
-
$56.21 M(-41.6%)
June 2022
-
$96.18 M(-4.3%)
Mar 2022
-
$100.47 M(-7.9%)
Dec 2021
$109.09 M(+110.3%)
$109.09 M(+39.7%)
Sept 2021
-
$78.07 M(+46.4%)
June 2021
-
$53.33 M(+7.2%)
Mar 2021
-
$49.74 M(-4.1%)
Dec 2020
$51.88 M(+95.4%)
$51.88 M(+5.0%)
Sept 2020
-
$49.43 M(+215.4%)
June 2020
-
$15.67 M(-36.2%)
Mar 2020
-
$24.58 M(-7.4%)
Dec 2019
$26.55 M
$26.55 M(+12.1%)
Sept 2019
-
$23.68 M(+4.0%)
June 2019
-
$22.76 M(-2.6%)
DateAnnualQuarterly
Mar 2019
-
$23.37 M(+16.4%)
Dec 2018
$20.07 M(+21.4%)
$20.07 M(+4.1%)
Sept 2018
-
$19.28 M(+12.6%)
June 2018
-
$17.12 M(+8.4%)
Mar 2018
-
$15.80 M(-4.4%)
Dec 2017
$16.53 M(+26.0%)
$16.53 M(+9.1%)
Sept 2017
-
$15.14 M(+14.1%)
June 2017
-
$13.27 M(+0.3%)
Mar 2017
-
$13.24 M(+0.9%)
Dec 2016
$13.12 M(+16.4%)
$13.12 M(+2.7%)
Sept 2016
-
$12.77 M(-11.7%)
June 2016
-
$14.46 M(+13.9%)
Mar 2016
-
$12.69 M(+12.6%)
Dec 2015
$11.27 M(+58.6%)
$11.27 M(+9.5%)
Sept 2015
-
$10.29 M(-2.3%)
June 2015
-
$10.54 M(+27.1%)
Mar 2015
-
$8.29 M(+16.7%)
Dec 2014
$7.11 M(+12.0%)
$7.11 M(+3.2%)
Sept 2014
-
$6.89 M(-0.6%)
June 2014
-
$6.93 M(+9.3%)
Dec 2013
$6.34 M(+1906.4%)
$6.34 M
Dec 2012
$316.10 K
-

FAQ

  • What is ProQR Therapeutics NV annual total liabilities?
  • What is the all time high annual total liabilities for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV annual total liabilities year-on-year change?
  • What is ProQR Therapeutics NV quarterly total liabilities?
  • What is the all time high quarterly total liabilities for ProQR Therapeutics NV?
  • What is ProQR Therapeutics NV quarterly total liabilities year-on-year change?

What is ProQR Therapeutics NV annual total liabilities?

The current annual total liabilities of PRQR is $106.66 M

What is the all time high annual total liabilities for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high annual total liabilities is $112.22 M

What is ProQR Therapeutics NV annual total liabilities year-on-year change?

Over the past year, PRQR annual total liabilities has changed by -$5.55 M (-4.95%)

What is ProQR Therapeutics NV quarterly total liabilities?

The current quarterly total liabilities of PRQR is $91.44 M

What is the all time high quarterly total liabilities for ProQR Therapeutics NV?

ProQR Therapeutics NV all-time high quarterly total liabilities is $112.22 M

What is ProQR Therapeutics NV quarterly total liabilities year-on-year change?

Over the past year, PRQR quarterly total liabilities has changed by -$9.85 M (-9.73%)